{
    "root": "3001bb01-7f73-716c-e063-6394a90a4915",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "lamivudine",
    "value": "20250310",
    "ingredients": [
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "LAMIVUDINE",
            "code": "2T8Q726O95"
        }
    ],
    "indications": "lamivudine oral solution , usp nucleoside analogue indicated combination antiretroviral agents treatment human immunodeficiency virus type 1 ( hiv-1 ) infection . limitations : product hiv-1 hbv .",
    "contraindications": "adults : 300 mg daily , administered either 150 mg twice daily 300 mg daily . ( 2.1 ) pediatric patients aged 3 months older : administered either twice daily . dose calculated body weight ( kg ) exceed 300 mg daily . ( 2.2 ) patients renal impairment : doses lamivudine must adjusted accordance renal function . ( 2.3 )",
    "warningsAndPrecautions": "lamivudine oral solution , usp clear , colorless pale yellow , strawberry flavored liquid . ml solution contains 10 mg lamivudine . packaged follows : plastic bottle 240 ml ( ndc 62135-706-37 ) child-resistant closure . unit-dose cup 30 ml ndc 62135-706-30 20 unit-dose cups 30 ml ndc 62135-706-24. product require reconstitution . recommended storage : store bottle 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "lamivudine oral solution contraindicated patients previous hypersensitivity reaction lamivudine .",
    "indications_original": "Lamivudine oral solution, USP is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.\n                  \n                     Limitations of Use:\n                  \n                  \n                     \u00a0The dosage of this product is for HIV-1 and not for HBV.",
    "contraindications_original": "Adults: 300 mg daily, administered as either 150 mg twice daily or 300 mg once daily. ( 2.1 ) Pediatric Patients Aged 3 Months and Older: Administered either once or twice daily. Dose should be calculated on body weight (kg) and should not exceed 300 mg daily. ( 2.2 ) Patients with Renal Impairment: Doses of lamivudine must be adjusted in accordance with renal function. ( 2.3 )",
    "warningsAndPrecautions_original": "Lamivudine Oral Solution, USP is a clear, colorless to pale yellow, strawberry flavored liquid. Each mL of the solution contains 10 mg of lamivudine. Packaged as follows:\n                  Plastic bottle of 240 mL (NDC 62135-706-37) with child-resistant closure.\n                  Unit-Dose cup 30 mL NDC 62135-706-30\n                  20 Unit-Dose Cups of 30 mL each NDC 62135-706-24.\n                  This product does not require reconstitution.\n                  Recommended Storage:\n                  Store bottle at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Lamivudine oral solution is contraindicated in patients with a previous hypersensitivity reaction to lamivudine."
}